Undifferentiated Connective Tissue Disease – Undifferentiated Connective Tissue Disease (UCTD) is an autoimmune disease that can affect several systems in the body. Connective tissue disease (CTD) is classified as undifferentiated CTD when signs and symptoms are consistent with a CTD, but do not fulfill the diagnostic or classification criteria for one of the previously defined CTD.
The underlying cause of UCTD is unknown, but it is a type of autoimmune disease, which means that the immune system malfunctions and mistakenly attacks a person’s own healthy tissues. The diagnosis is made by ruling out other conditions that can cause the same symptoms, aided by blood and urine tests, and imaging studies such as X-ray, CT scan, or ultrasound.
Undifferentiated Connective Tissue Disease Symptoms
- Raynaud’s Phenomenon
- eye and mouth dryness
- joint pain
- Antibody Test
- Vitamin b12
- HIV Test
Treatment for Undifferentiated Connective Tissue Disease
Treatment for the symptoms of undifferentiated connective tissue (UCTD) disease typically involves the use of nonsteroidal anti-inflammatory drugs, antimalarial drugs, and/or corticosteroids. In people with severe signs and symptoms, drugs that suppress the immune system may be recommended.
A variety of other types of medications may be considered on an individual basis, such as calcium channel blockers for symptoms of Raynaud phenomenon. People with Raynaud phenomenon should also avoid exposure to very cold temperatures. Those with increased sensitivity to sunlight should try to minimize being exposed to sunlight for long periods of time. Wearing protective clothing and sunblock also helps protect against the effects of ultraviolet light.